[Printing Process Quality Control of Bioprinting Medical Devices]

Area of Science:

• Bioprinting technology
• Medical device quality control
• Bioink development

Context:

• Bioprinting medical devices are rapidly advancing.
• Ensuring the safety and efficacy of these devices is critical.
• Existing regulatory frameworks require examination for bioprinting applications.

Purpose:

• Analyze quality control risk points in bioink and bioprinting processes.
• Explore regulatory models for bioprinting medical devices.
• Provide guidance for ensuring device safety and effectiveness.

Summary:

• Comprehensive analysis of quality control risks in bioprinting materials and processes.
• Examination of regulatory models and methods for bioprinting medical devices.
• Focus on extrusion, laser-assisted, and in situ bioprinting technologies, including clinical and regulatory challenges.

Impact:

• Bioink must meet stringent regulatory requirements, including aseptic handling and validated sterilization.
• Concurrent research in materials, processes, and quality risk control is essential for regulatory system development.
• This work contributes to the advancement of the bioprinting industry and public health.